United Therapeutics | UTHR - El Costo De Ventas





El Costo De Ventas Cambio Fecha
Amarin USD 26.05M 1.41M 2025-12
Ardelyx USD 10.85M 6.87M 2025-12
Baxter International USD 2.4B 512M 2025-12
Bayer EUR 4.5B 194M 2025-12
BioCryst Pharmaceuticals USD 9.52M 7.34M 2025-12
Biogen USD 797.5M 302M 2026-03
BioMarin Pharmaceutical USD 161.56M 16.62M 2025-12
Emergent BioSolutions USD 381.2M 226.1M 2023-06
Esperion Therapeutics USD 27.85M 13.43M 2025-12
Gilead Sciences USD 1.62B 50M 2025-12
GlaxoSmithKline GBP 1.88B 736M 2026-03
Halozyme Therapeutics USD 102.15M 29.14M 2025-12
Insmed USD 46.16M 15.25M 2025-12
Ionis Pharmaceuticals USD 3M 5M 2026-03
J&J USD 8.07B 103M 2026-03
Lexicon Pharmaceuticals USD 201K 191K 2025-12
Moderna USD 452M 245M 2025-12
Omeros USD 33.16M 18.52M 2024-06
Pfizer USD 6.29B 2.12B 2025-12
PTC Therapeutics USD 16.3M 7.02M 2025-12
Regeneron Pharmaceuticals USD 669.4M 84.8M 2026-03
Sangamo BioSciences 2.42M 1.11M 2024-06
Sarepta Therapeutics USD 399.38M 247.93M 2025-12
Teva Pharmaceutical Industries USD 2.01B 46M 2026-03
United Therapeutics USD 474.7M 373.8M 2025-12
Vertex Pharmaceuticals USD 466M 51.2M 2025-12